Stroke :: Limiting stroke damage is focus of study
Brain damage that occurs even days after a stroke, increasing stroke size and devastation, is the focus of researchers trying to identify new treatments.
Stroke
Heart :: Study questions risks of anti-bleeding drug during heart surgery
Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of the Journal of Thoracic and Cardiovascular Surgery.
Alzheimer’s Disease :: Blood inflammation plays role in Alzheimer’s disease
People whose blood shows signs of inflammation are more likely to later develop Alzheimer’s disease than people with no signs of inflammation, according to a study published in the May 29, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
Epilepsy :: Human Herpes Virus 6B is associated with mesial temporal lobe epilepsy
There is strong evidence that one particular type of epilepsy is associated with a viral infection, report researchers in PLoS Medicine this week.
Stroke :: New device for stroke patients improves walking
Among stroke survivors, one common difficulty is foot drop, a partial leg paralysis that prevents the foot from lifting — causing instability and difficulty walking.
Heart Attack :: Fish oil good for heart attack patients
Fish oil supplements are considered good for heart attack patients, and could prevent a repeat attack of survivors of cardiac arrest, MI.
Avandia :: American College of Cardiology, American Diabetes Association, American Heart Association on Avandia
The following is a Statement from the American College of Cardiology, American Diabetes Association and American Heart Association Related to NEJM article, ‘Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes’:
Heart Disease :: Heart patients discontinue medicines without doctor’s advice
Cardiovascular disease (heart disease, stroke and vascular disease) affects nearly one in five Australians and about 65% of those take medicines for their condition.
Menopause :: COX Inhibitors May Weaken Protective Qualities of Estrogen Hormone Therapy
Researchers from the University of Pennsylvania School of Medicine found in a database study of women heart patients that COX inhibitors such as traditional nonsteroidal anti-inflammatory drugs (NSAIDs) may undermine any purported protection against heart disease in participants taking estrogen therapy. The results were described this week in PLoS Medicine.
Diabetes :: GlaxoSmithKline responds to NEJM article on Avandia
GlaxoSmithKline [NYSE:GSK] issued the following response to an article in the New England Journal of Medicine (NEJM) on Avandia? (rosiglitazone maleate), a widely used and highly effective treatment for type 2 diabetes: